These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9781435

  • 1. Incidence of lymph node metastasis and its impact on long-term prognosis in clinically localized prostate cancer.
    Arai Y, Kanamaru H, Yoshimura K, Okubo K, Kamoto T, Yoshida O.
    Int J Urol; 1998 Sep; 5(5):459-65. PubMed ID: 9781435
    [Abstract] [Full Text] [Related]

  • 2. Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era.
    Kakehi Y, Kamoto T, Okuno H, Terai A, Terachi T, Ogawa O.
    Int J Urol; 2000 Aug; 7(8):281-6. PubMed ID: 10976815
    [Abstract] [Full Text] [Related]

  • 3. Pelvic lymph node dissection in prostate cancer.
    Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
    Sengupta S, Weerakoon M, Sethi K, Ischia J, Webb DR.
    BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
    [Abstract] [Full Text] [Related]

  • 7. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
    Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A.
    Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
    [Abstract] [Full Text] [Related]

  • 8. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG.
    Cancer; 2001 Jan 01; 91(1):66-73. PubMed ID: 11148561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F, Bandini M, Marchioni M, Nazzani S, Tian Z, Pompe RS, Fossati N, Briganti A, Saad F, Shariat SF, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.
    Prostate; 2018 May 01; 78(6):469-475. PubMed ID: 29460290
    [Abstract] [Full Text] [Related]

  • 12. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M, Babaian K, Achim MF, Achim GC, Troncoso P, Matin SF, Chapin BF, Davis JW.
    BJU Int; 2018 Jul 01; 122(1):66-75. PubMed ID: 29446205
    [Abstract] [Full Text] [Related]

  • 13. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun 01; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 14. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A, Varga Z, Von Knobloch R.
    J Urol; 2002 Apr 01; 167(4):1681-6. PubMed ID: 11912387
    [Abstract] [Full Text] [Related]

  • 15. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.
    BJU Int; 2011 Jun 01; 107(11):1755-61. PubMed ID: 20942833
    [Abstract] [Full Text] [Related]

  • 16. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr 01; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 17. Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy.
    Schmid HP, Mihatsch MJ, Hering F, Rutishauser G.
    Eur Urol; 1997 Apr 01; 31(1):11-6. PubMed ID: 9032528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mini-laparotomy staging pelvic lymph node dissection for localized prostate cancer.
    Arai Y, Ishitoya S, Okuba K, Kanba T, Shichiri Y, Suzuki Y.
    Int J Urol; 1995 May 01; 2(2):121-3. PubMed ID: 7553284
    [Abstract] [Full Text] [Related]

  • 20. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N, Larcher A, Haese A, Ficarra V, Govorov A, Buffi NM, Walz J, Rocco B, Borghesi M, Steuber T, Pini G, Briganti A, Mottrie AM, Guazzoni G, Montorsi F, Pushkar D, Van Der Poel H, EAU Young Academic Urologists–Robotic Section.
    Eur Urol; 2014 Oct 01; 66(4):635-43. PubMed ID: 24411992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.